Multimodality management of malignant pleural mesothelioma

Chest

Volumn 113, Issue 1 SUPPL., 1998, Pages 61S-65S

  Sugarbaker, David J ^a,b,c   Norberto, Jose J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW;

EID: 0031985597     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.1_Supplement.61S     Document Type: Article

References (22)

1. Antman KH, Pass HI, DeLaney T, et al. Benign and malignant mesothelioma. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott, 1993; 1489-1508
2. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994; 9:1781-90
3. Walker AM, Loughlin JE, Freidlander ER, et al. Projections of asbestos-related disease 1980-2009. J Occup Med 1983; 25:409-25
4. Enterline PE, Henderson VL. Geographic patterns of pleural mesothelioma deaths in the United States, 1968-81. J Natl Cancer Inst 1987; 79:31-37
5. Antman K, Pass HI, Recht A. Benign and malignant mesothelioma. In: DeVita VT Jr, Hellman S, Rosenborg SA, eds. Cancer: principles and practice of oncology. 3rd ed. Philadelphia: JB Lippincott, 1989; 1399-1414
6. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989; 7:1157-68
7. Sugarbaker DJ, Heher EC. Lee TH, et al. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1991; 102:10-14
8. Patz EF Jr, Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992; 159:961-66
9. Corson JM. Pathology of mesothelioma. In: Antman K, Aisner J, eds. Asbestos-related malignancy. Orlando, Fla: Grune & Stratton, 1986; 179-99
10. Butchart EG, Ashcroft T, Barnsley WC, et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 1976; 31:15-24
11. Rusch VW, Ginsberg RJ. New concepts in the staging of mesothelioma: invited comment to chapter 26. In: Deslauriers J, Lacquet LK, eds. Thoracic surgery: surgical management of pleural diseases: international trends in general thoracic surgery (vol 6). St. Louis: CV Mosby, 1990; 336-43
12. Sugarbaker DJ, Strauss GM, Lynch TJ, et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993; 11:1172-78
13. Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg 1996; 224:288-96
14. Worn H. Moglichkeiten und ergebnisse der chirurgischen behandlung des malignen pleuramesotheliomas. Thoraxchir Vask Chir 1974; 22:391-93
15. Rusch VW. Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: a Lung Cancer Study Group trial [see comments]. J Thorac Cardiovasc Surg 1991; 102:1-9
16. Gordon W Jr. Antman KH, Greenberger JS, et al. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982; 8:19-25
17. McCormack PM, Nagasaki F, Hilaris BS, et al. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 1982; 84:834-42
18. Rusch V, Saltz L, Venkatraman E, et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 1994; 12:1156-63
19. Rusch VW. Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1996; 111:815-26
20. Sarot IA. Extrapleural pneumonectomy and pleurectomy in pulmonary tuberculosis. Thorax 1949; 4:173-223
21. Hood RM, Antman K, Boyd A, et al. Surgical diseases of the pleura and chest wall. Philadelphia: WB Saunders, 1986
22. Moran JF. Surgical treatment of pulmonary tuberculosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: WB Saunders, 1990: 690-707